September 29, 2010
The Peripheral Arterial Disease (P.A.D.) Coalition presented its
annual Stay in Circulation Community
Service Award to Parrish Medical Center, Titusville, Fla, at the organization’s
seventh annual meeting. The Stay in Circulation Community Service Award recognizes
collaborative programs focused on increasing awareness about peripheral arterial
disease to high-risk populations, patients and/or the health care
Marialice Knight, RN, BSN,
Parrish Medical Center cardiovascular community RN
and P.A.D. program coordinator accepted the award on the medical center’s
Medical Center is extremely honored to receive this award,” said Knight. “Our
P.A.D. community program is a seven-year collaborative effort of our hospital
board of directors, administration, foundation, staff members and our P.A.D.
physicians. We are dedicated to the continued support of the Coalition’s mission
and to continue to identify individuals with P.A.D. and assure they receive the
same risk reduction and specific treatment as those with coronary artery
Peripheral arterial disease
occurs when arteries in the legs become narrowed or clogged with fatty deposits,
reducing blood flow to the legs. This can result in leg muscle pain when
walking, disability, amputation and a poor quality of life. Blocked leg arteries
found in people with P.A.D. can be a warning sign that other arteries, including
those in the heart and brain, may also be affected—increasing the risk of a
heart attack or stroke.
Parrish Medical Center
received the P.A.D. Community Service Award for its innovative and comprehensive
approach to P.A.D outreach and education. The Center built a local P.A.D.
network, a multidisciplinary collaborative that served to educate the health
care community and at risk individuals about P.A.D. Since 2005, Parrish Medical
Center has coordinated approximately 100 P.A.D. awareness presentations to
hospital staff, local clinicians, city employees and a variety of other
audiences, and has completed nearly 2,500 P.A.D. screening tests for community
members. The center was able to accomplish this with seed money provided by the
Jess Parrish Medical Foundation to purchase P.A.D. screening
Community access to free,
year round P.A.D. screenings provides a tool to identify patients at risk for
cardiovascular and peripheral arterial disease. PMC has enhanced physician
relationships with primary care, cardiology, internal medicine and other
subspecialties by assisting them in their efforts to prevent and identify P.A.D.
in their patient population. In particular, a targeted partnership with 12 local
physician practices has proven to be a successful coordination of education,
training and standardization of practice for the detection and treatment of
P.A.D. Media efforts have supplemented all activities and successfully worked to
further P.A.D. messages within the community.
"On behalf of the P.A.D.
Coalition, we are delighted to present the third annual Community Service Award
to Parrish Medical Center," said Marge Lovell, RN,
Chair, P.A.D. Coalition and clinical trials nurse at the London Health Sciences
and Centre in London, Ontario. “Their efforts serve as a model program to
reach entire communities with P.A.D. messages to help reduce the devastating
consequences of the disease.”
For more information about
P.A.D., visit www.P.A.D.coalition.org.
The Peripheral Arterial Disease (P.A.D.)
Coalition is an international alliance of more than 80 North American and
European health organizations, professional societies, government agencies and
corporations united to improve the health and care of patients with P.A.D.
Established in 2004, the P.A.D. Coalition is a division of the Vascular Disease
Foundation (www.vdf.org), a national, not-for-profit section
501(c)(3) organization. The P.A.D. Coalition is supported by the following
national sponsors: the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership;
Cordis Endovascular, a division of Cordis Corporation; Abbott Vascular;
AstraZeneca; Bard Peripheral Vascular; BioMedix; Cook, Inc; ev3 Endovascular,
Inc.; W.L. Gore & Associates; Hokanson; PADTest; and Summit